Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anticancer/sarcoma

Lyen an sove nan clipboard la
Paj 1 soti nan 55 rezilta yo

Mitomycin compounds having useful anti-tumor activity

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention relates to new mitomycin derivatives having excellent anti-tumour activities and which are of interest in the preparation of anti-tumour compositions. It is known that mitomycins have, in general, excellent anti-tumour activities. Examples of these mitomycins include mitomycin

Antitumor antibiotic macracidmycin

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a new antitumor antibiotic substance and to its production. More particularly, it relates to a new antitumor antibiotic substance designated macracidmycin and to processes for the preparation thereof by the fermentation

Substance AX-2, a process for producing the same and an antitumor composition containing the same

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION This invention relates to a new substance having anti-tumour activity, a process for producing the same by fermentation and an antitumour composition containing the same. It was previously known to produce mitomycin A and/or B by fermentation, which process comprises

Cancer treatment

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD A method of treating cancer, including carcinomas and sarcomas is claimed. The pharmaceutical composition containing compounds is also claimed. BACKGROUND OF THE INVENTION Cancers are a leading cause of death in animals and humans. The exact cause of cancer is not known, but links

3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine having anti-tumor activity

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION The present invention relates to a novel compound, compositions containing the compound, the use of the compound in inhibiting the growth of malignant neoplasms in mammals, and a method of preparing the compound. A number of chemicals that inhibit the growth or otherwise

Antitumor antibiotics MA 144-M.sub.1 and MA 144-M.sub.2

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to new anthracycline glycoside antitumor antibiotics, to processes for their preparation and to pharmaceutical compositions containing them. More, particularly, it relates to new antitumor antibiotics designated MA

Mixture having antitumor activities

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
SUMMARY OF THE INVENTION Tice.RTM. substrain BCG is used clinically as an immunotherapeutic agent against superficial bladder cancer. A boiling water extract of this BCG showed antitumor activity against a murine S180 sarcoma model and was fractionated into three fractions, A, B and C, by the use of

Polysaccharide RBS substance and antitumor agent containing same

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel polysaccharide RBS substance and antitumor agent containing said substance as the effective component. 2. Description of the Prior Art As is known in the art, polysaccharides are obtained from various sources,

Methods for anti-tumor therapy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION Approximately twenty percent of deaths from all causes in the United States are cancer-related. Although chemotherapy is a principal means of cancer treatment, the rate at which effective new drugs have become available for use in cancer chemotherapy has not increased

Method of inhibiting leukemias and sarcomas in a mammalian host

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
INTRODUCTION The present invention relates generally to a new antineoplastic substance denominated "pancratistatin", its synthetic counterpart and pharmaceutically acceptable derivatives thereof. The invention further comprises methods for obtaining pancratistatin and 7-deoxynarciclasine, procedures

Composition of matter for inhibiting leukemias and sarcomas

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
INTRODUCTION The present invention relates generally to a new antineoplastic substance denominated "pancratistatin", its synthetic counterpart and pharmaceutically acceptable derivatives thereof. The invention further comprises methods for obtaining pancratistatin and 7-deoxynarciclasine,

Use of ureidomustine (BO-1055) in cancer treatment

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION Ever since President Nixon's 1971 declaration of "War on Cancer," a set of assumptions has dominated cancer treatment for over 40 years. A war on cancer is a powerfully evocative metaphor that is directly responsible for a counterproductive and even potentially dangerous

Anti-cancer pharmaceutical compositions and methods for treating patients with cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD The present invention relates to (a) an anti-cancer pharmaceutical composition which contains a thiazolidinedione compound having a peroxisome proliferators activated receptor (PPAR).gamma. activation potency as an active ingredient, and to (b) an anti-cancer pharmaceutical

Anti-cancer drugs, and uses relating for malignant melanoma and other cancers

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION The present invention relates to Selenophene compounds and Selenophene triazene compounds, their geometrical isomeric forms, stereoisomers, configurational isomers, polymorphs, hydrates, solvates and pharmaceutically acceptable salts thereof. The present invention further

Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION The present invention relates to triazene analogs of the general formula (I) and formula (II), their tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, and pharmaceutically acceptable salts thereof for the metastatic malignant melanoma and other cancers including
Antre nan paj
facebook nou an

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

  • Travay nan 55 lang
  • Geri èrbal te apiye nan syans
  • Remèd fèy rekonesans pa imaj
  • Kat entèaktif GPS - tag zèb sou kote (vini byento)
  • Li piblikasyon syantifik ki gen rapò ak rechèch ou an
  • Search remèd fèy medsin pa efè yo
  • Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

Google Play badgeApp Store badge